Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederthelancet.com
The Lancet
Get the latest updates from The Lancet directly as they happen.
Follow now 95 followers
Latest posts
Last updated about 10 hours ago
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial
about 10 hours ago
Minocycline therapy initiated within 72 h of acute ischaemic stroke provided a...
US forced deportation, language exclusion, and disability justice
about 10 hours ago
Deportation practices in the USA continue to undermine the communication and disability...
Lessons from Somalia's One Health programme and Pandemic Fund
about 10 hours ago
Pandemic preparedness in fragile and conflict-affected states is shaped less by technical...
Continued hope for late neuroprotection with minocycline
about 10 hours ago
Neuroprotection in ischaemic stroke commonly means a treatment that results in the...
The rationale for a European Defence Health Agency
about 10 hours ago
In Berlin, Germany, on Dec 11, 2025, NATO's Chief, Mark Rutte, warned...
Violations of medical neutrality during protests in Iran
about 10 hours ago
Hospitals are protected spaces under international humanitarian law, including the Geneva Conventions...
A 25% extraterritorial tariff shock and the health burden in Iran
1 day ago
Iran is facing a humanitarian crisis, with widespread reports of deaths.1 With...
Governance for health in a turbulent world: introducing a new Lancet Commission
1 day ago
Over a decade has elapsed since the Lancet–University of Oslo Commission on...
Implementation first: lessons from the TRICORDER trial in UK primary care
2 days ago
Primary care faces a growing workload and limited resources, making it the...
Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial
2 days ago
Implementation of an AI stethoscope in routine primary care did not significantly...
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
3 days ago
BI 764198 lowered proteinuria and was well tolerated by participants in this...
TRPC6 inhibition: podocyte-targeted treatment for focal segmental glomerulosclerosis?
3 days ago
Focal segmental glomerulosclerosis (FSGS) is a histological pattern of kidney damage.1 While...